A return to normalcy requires us to address the limits of current testing approaches and broadly deploy reliable screening tools that facilitate early detection and encourage more focused testing of those at high-risk of spreading the coronavirus.
A review of new, successful treatment options for the novel coronavirus.
The serology test is the first of its kind to detect neutralizing antibodies from a recent or prior SARS-CoV-2 infection.
With everything to gain, telehealth may lead to a new standard in health/wellness treatment while at the same time unifying the entire healthcare ecosystem.
The pace of innovation in the ICU is orders of magnitude slower than that of the cath lab and OR, and the COVID-19 crisis has pushed, tested, and exposed ICUs for lacking state-of-the-art technology and resources.
Illumina’s COVIDSeq Test enables qualitative detection of SARS-CoV-2 RNA from respiratory specimens.
These countries have been more successful with managing the virus than the United States and the European Union.
COVID-19 requires us to rethink our current device disinfection procedure.
During an outbreak, it is critical to treat reusable medical devices as potential sources of transmission.
The idea of harnessing the body’s response to heal and defend is no longer the stuff of science fiction.